| 5867- | CA, | Inhibitory effects of rosemary extracts, carnosic acid and rosmarinic acid on the growth of various human cancer cell lines |
| - | in-vitro, | Pca, | DU145 | - | in-vitro, | Liver, | Hep3B | - | in-vitro, | AML, | K562 | - | in-vitro, | Pca, | PC3 | - | in-vitro, | BC, | MDA-MB-231 |
| 5868- | CA, | Carnosic acid inhibits the proliferation and migration capacity of human colorectal cancer cells |
| - | in-vitro, | Colon, | Caco-2 | - | in-vitro, | Colon, | HT29 | - | in-vitro, | CRC, | LoVo |
| 5869- | CA, | Carnosic Acid Induces Antiproliferation and Anti-Metastatic Property of Esophageal Cancer Cells via MAPK Signaling Pathways |
| - | in-vitro, | ESCC, | KYSE150 |
| 5870- | CA, | Carnosic Acid Mediates Production of Reactive Oxygen Species to Regulate Mitogen‐Activated Protein Kinase Pathway Phosphorylation and Induce Apoptosis in Human Breast Cancer Cells |
| - | vitro+vivo, | BC, | T47D | - | in-vitro, | BC, | MCF-7 |
| 5871- | CA, | Carnosic Acid Attenuates an Early Increase in ROS Levels during Adipocyte Differentiation by Suppressing Translation of Nox4 and Inducing Translation of Antioxidant Enzymes |
| - | in-vitro, | Nor, | NA |
| 5876- | CA, | Carnosic acid, a rosemary phenolic compound, induces apoptosis through reactive oxygen species-mediated p38 activation in human neuroblastoma IMR-32 cells |
| - | in-vitro, | neuroblastoma, | NA |
| 5875- | CA, | Carnosic acid prevents dextran sulfate sodium-induced acute colitis associated with the regulation of the Keap1/Nrf2 pathway |
| - | in-vivo, | IBD, | NA |
| 5874- | CA, | Carnosic Acid Mediates Production of Reactive Oxygen Species to Regulate Mitogen-Activated Protein Kinase Pathway Phosphorylation and Induce Apoptosis in Human Breast Cancer Cells |
| - | vitro+vivo, | BC, | T47D | - | in-vitro, | BC, | MCF10 |
| 5774- | CA, | CAPE, | Caffeic Acid Versus Caffeic Acid Phenethyl Ester in the Treatment of Breast Cancer MCF-7 Cells: Migration Rate Inhibition |
| - | NA, | BC, | MCF-7 |
| 5872- | CA, | Nrf2/ARE-Mediated Antioxidant Actions of Pro-Electrophilic Drugs |
| - | Review, | Nor, | NA |
| 5873- | CA, | Carnosic acid serves as a dual Nrf2 activator and PTEN/AKT suppressor to inhibit traumatic heterotopic ossification |
| - | vitro+vivo, | Nor, | NA |
| 5924- | CA, | Carnosic acid impedes cell growth and enhances anticancer effects of carmustine and lomustine in melanoma |
| - | vitro+vivo, | Melanoma, | B16-F10 |
| 5923- | CA, | RosA, | Rosemary as a Potential Source of Natural Antioxidants and Anticancer Agents: A Molecular Docking Study |
| - | Review, | Var, | NA |
| 3032- | CA, | Carnosic Acid Induces Apoptosis Through Reactive Oxygen Species-mediated Endoplasmic Reticulum Stress Induction in Human Renal Carcinoma Caki Cells |
| - | in-vitro, | Kidney, | Caki-1 |
| 2399- | CA, | EA, | Polyphenol-rich diet mediates interplay between macrophage-neutrophil and gut microbiota to alleviate intestinal inflammation |
| - | Review, | Col, | NA |
| - | Analysis, | AD, | NA |
| 3791- | CA, | Caffeic Acid and Diseases—Mechanisms of Action |
| - | Review, | AD, | NA |
| - | Study, | AD, | NA |
| 1011- | CA, | Dihydrocaffeic acid improves IL-1β-induced inflammation and cartilage degradation via inhibiting NF-κB and MAPK signalling pathways |
| - | in-vivo, | NA, | NA |
| 1101- | CA, | Tras, | Cooperative antitumor activities of carnosic acid and Trastuzumab in ERBB2+ breast cancer cells |
| - | in-vitro, | BC, | NA |
| 145- | CA, | CUR, | The anti-cancer effects of carotenoids and other phytonutrients resides in their combined activity |
| - | in-vitro, | Pca, | LNCaP | - | in-vitro, | Pca, | PC3 | - | in-vitro, | PC, | DU145 |
| 4263- | CA, | Neuroprotective Effects of Carnosic Acid: Insight into Its Mechanisms of Action |
| - | Review, | AD, | NA |
| 4264- | CA, | Carnosic Acid Mitigates Depression-Like Behavior in Ovariectomized Mice via Activation of Nrf2HO-1 Pathway |
| - | in-vivo, | NA, | NA |
| 4265- | CA, | Potential applications of nanomedicine for treating Parkinson's disease |
| - | Review, | Park, | NA |
| 4342- | CA, | Antiplatelet effects of caffeic acid due to Ca(2+) mobilizationinhibition via cAMP-dependent inositol-1, 4, 5-trisphosphate receptor phosphorylation |
| - | in-vitro, | NA, | NA |
| 4268- | Caff, | Modulatory effect of coffee fruit extract on plasma levels of brain-derived neurotrophic factor in healthy subjects |
| - | Study, | NA, | NA |
| 4267- | Caff, | Caffeine‐mediated BDNF release regulates long‐term synaptic plasticity through activation of IRS2 signaling |
| - | in-vivo, | NA, | NA |
| 1206- | Caff, | Caffeine inhibits TGFβ activation in epithelial cells, interrupts fibroblast responses to TGFβ, and reduces established fibrosis in ex vivo precision-cut lung slices |
| - | in-vitro, | NA, | NA | - | ex-vivo, | NA, | NA |
| 1205- | Caff, | immuno, | Caffeine-enhanced anti-tumor activity of anti-PD1 monoclonal antibody |
| - | in-vivo, | Melanoma, | B16-F10 |
| 1653- | Caff, | Higher Caffeinated Coffee Intake Is Associated with Reduced Malignant Melanoma Risk: A Meta-Analysis Study |
| - | Review, | Melanoma, | NA |
| 4161- | Caff, | Chronic caffeine prevents changes in inhibitory avoidance memory and hippocampal BDNF immunocontent in middle-aged rats |
| - | in-vivo, | AD, | NA |
| 5778- | Calc, | VitD3, | Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a meta-analysis of 26,335 cases from 60 observational studies |
| - | Study, | CRC, | NA |
| 5777- | Calc, | Calcium intake and colorectal cancer risk: dose-response meta-analysis of prospective observational studies |
| - | Study, | CRC, | NA |
| 5775- | Calc, | Calcium Intake and Risk of Colorectal Cancer in the NIH-AARP Diet and Health Study |
| - | Study, | CRC, | NA |
| 5776- | Calc, | Calcium |
| - | Review, | Var, | NA |
| 5779- | Calc, | Calcium supplementation for the prevention of colorectal adenomas: A systematic review and meta-analysis of randomized controlled trials |
| - | Study, | CRC, | NA |
| 5842- | CAP, | Capsaicin: Current Understanding of Its Mechanisms and Therapy of Pain and Other Pre-Clinical and Clinical Uses |
| - | Review, | Nor, | NA | - | Review, | Diabetic, | NA |
| 5841- | CAP, | The red pepper’s spicy ingredient capsaicin activates AMPK in HepG2 cells through CaMKKβ |
| - | in-vitro, | HCC, | HepG2 |
| 5840- | CAP, | Dietary compounds as potent inhibitors of the signal transducers and activators of transcription (STAT) 3 regulatory network |
| - | Review, | Var, | NA |
| 5839- | CAP, | Capsaicin: beyond TRPV1 |
| - | Review, | Var, | NA |
| 5838- | CAP, | Capsaicin Induces Autophagy and Apoptosis in Human Nasopharyngeal Carcinoma Cells by Downregulating the PI3K/AKT/mTOR Pathway |
| - | in-vitro, | NPC, | NA |
| 5837- | CAP, | Capsaicin triggers immunogenic PEL cell death, stimulates DCs and reverts PEL-induced immune suppression |
| - | in-vitro, | lymphoma, | PEL |
| 5836- | CAP, | In vitro and in vivo induction of apoptosis by capsaicin in pancreatic cancer cells is mediated through ROS generation and mitochondrial death pathway |
| - | vitro+vivo, | PC, | AsPC-1 | - | in-vitro, | PC, | Bxpc-3 |
| 5835- | CAP, | Capsaicin and dihydrocapsaicin induce apoptosis in human glioma cells via ROS and Ca2+-mediated mitochondrial pathway |
| - | in-vitro, | GBM, | U251 |
| 5834- | CAP, | Capsaicin and TRPV1: A Novel Therapeutic Approach to Mitigate Vascular Aging |
| - | Study, | Nor, | NA |
| 5833- | CAP, | Capsaicin: From Plants to a Cancer-Suppressing Agent |
| - | Review, | Var, | NA |
| 5832- | CAP, | Capsaicin induces cell cycle arrest and apoptosis in human KB cancer cells |
| - | in-vitro, | Oral, | KB |
| 5831- | CAP, | Unraveling TRPV1’s Role in Cancer: Expression, Modulation, and Therapeutic Opportunities with Capsaicin |
| 5830- | CAP, | Inhibition of pyroptosis and apoptosis by capsaicin protects against LPS-induced acute kidney injury through TRPV1/UCP2 axis in vitro |
| - | in-vitro, | Nor, | HK-2 |
| 5825- | CAP, | Bioavailability of capsaicin and its implications for drug delivery |
| - | Review, | Var, | NA | - | Review, | Arthritis, | NA | - | Review, | Obesity, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid